ASML vs CIEN

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

Ciena Corporation exhibits a stable financial health profile with a Piotroski F-Score of 4/9, but is currently experiencing a severe valuation decoupling. The current price of $520.80 is astronomically higher than both the Graham Number ($26.32) and the growth-based Intrinsic Value ($46.02). While the company shows explosive earnings growth and strong liquidity, the P/E ratio of 333.85 and a bearish technical trend (10/100) suggest the stock is in a speculative bubble. Furthermore, the current price sits significantly above the analyst target mean of $378.11, indicating substantial downside risk.